TXG Cash & Short-Term Investments

10X Genomics Inc Class A · Cash & Short-Term Investments

TXG logo

TXG Cash & Short-Term Investments

Latest reported$523.41M
TXG FY Cash & Short-Term Investments ($47.86M → $523.41M)
High-resolution chart · PNG

TXG cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

10X Genomics Inc Class A Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
523,409,000
393,402,000
388,695,000
429,984,000
587,447,000
663,603,000
424,166,000
65,080,000
47,857,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.